Series A · Biotech
Anodyne Nanotech: Series A
Develops transdermal microneedle patches delivering GLP-1 and biologic therapeutics without injections
Funding history
Series A · This round$12.6M
Loading rounds…
Develops transdermal microneedle patches delivering GLP-1 and biologic therapeutics without injections